chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling abnormal, Lymph node pain, Mass, Muscle spasms
Clinical narrative: arm red and swollen; Tenderness and swelling of the lymph nodes; swelling of the lymph nodes in the same arm of the injection; i fell like a ball; cramps on my legs \ cramps; very bad body aches; knots in the legs \ in the thigh above the knee \ in the foot; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm red and swollen), LYMPH NODE PAIN (Tenderness and swelling of the lymph nodes), VACCINATION SITE LYMPHADENOPATHY (swelling of the lymph nodes in the same arm of the injection), FEELING ABNORMAL (i fell like a ball) and MYALGIA (very bad body aches) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  No concomitant medication reported.     On 24-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced MYALGIA (very bad body aches) and MASS (knots in the legs \ in the thigh above the knee \ in the foot). On 27-Apr-2021, the patient experienced MUSCLE SPASMS (cramps on my legs \ cramps). On 28-Apr-2021, the patient experienced FEELING ABNORMAL (i fell like a ball). On an unknown date, the patient experienced ERYTHEMA (arm red and swollen), LYMPH NODE PAIN (Tenderness and swelling of the lymph nodes) and VACCINATION SITE LYMPHADENOPATHY (swelling of the lymph nodes in the same arm of the injection). At the time of the report, ERYTHEMA (arm red and swollen), VACCINATION SITE LYMPHADENOPATHY (swelling of the lymph nodes in the same arm of the injection), FEELING ABNORMAL (i fell like a ball), MYALGIA (very bad body aches), MASS (knots in the legs \ in the thigh above the knee \ in the foot) and MUSCLE SPASMS (cramps on my legs \ cramps) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment with Ibuprofen on 25 an 26 April 2021 ,pertained to the events , were provided.   This case was linked to MOD-2021-095235 (E2B Linked Report).; Sender's Comments:  MOD-2021-095235:First dose
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site lymphadenopathy
Clinical narrative: arm red and swollen; Tenderness and swelling of the lymph nodes; swelling of the lymph nodes in the same arm of the injection; i fell like a ball; cramps on my legs \ cramps; very bad body aches; knots in the legs \ in the thigh above the knee \ in the foot; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm red and swollen), LYMPH NODE PAIN (Tenderness and swelling of the lymph nodes), VACCINATION SITE LYMPHADENOPATHY (swelling of the lymph nodes in the same arm of the injection), FEELING ABNORMAL (i fell like a ball) and MYALGIA (very bad body aches) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  No concomitant medication reported.     On 24-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced MYALGIA (very bad body aches) and MASS (knots in the legs \ in the thigh above the knee \ in the foot). On 27-Apr-2021, the patient experienced MUSCLE SPASMS (cramps on my legs \ cramps). On 28-Apr-2021, the patient experienced FEELING ABNORMAL (i fell like a ball). On an unknown date, the patient experienced ERYTHEMA (arm red and swollen), LYMPH NODE PAIN (Tenderness and swelling of the lymph nodes) and VACCINATION SITE LYMPHADENOPATHY (swelling of the lymph nodes in the same arm of the injection). At the time of the report, ERYTHEMA (arm red and swollen), VACCINATION SITE LYMPHADENOPATHY (swelling of the lymph nodes in the same arm of the injection), FEELING ABNORMAL (i fell like a ball), MYALGIA (very bad body aches), MASS (knots in the legs \ in the thigh above the knee \ in the foot) and MUSCLE SPASMS (cramps on my legs \ cramps) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment with Ibuprofen on 25 an 26 April 2021 ,pertained to the events , were provided.   This case was linked to MOD-2021-095235 (E2B Linked Report).; Sender's Comments:  MOD-2021-095235:First dose
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: he had a fever of 100.9 F/fever of 101.3 F; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (he had a fever of 100.9 F/fever of 101.3 F) and CHILLS (chills) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 018B21A) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced CHILLS (chills). On 28-Apr-2021 at 5:00 AM, the patient experienced PYREXIA (he had a fever of 100.9 F/fever of 101.3 F). At the time of the report, PYREXIA (he had a fever of 100.9 F/fever of 101.3 F) and CHILLS (chills) outcome was unknown.       It was reported that the patient took acetaminophen for the adverse events.   This case was linked to US-MODERNATX, INC.-MOD-2021-095036 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-095036:Case for dose 1
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, Product dose omission issue
Clinical narrative: weakness; feeling out of balance; missed second dose (88 days since first one); This spontaneous case was reported by a physician and describes the occurrence of ASTHENIA (weakness), BALANCE DISORDER (feeling out of balance) and PRODUCT DOSE OMISSION ISSUE (missed second dose (88 days since first one)) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. M20A) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), BALANCE DISORDER (feeling out of balance) and PRODUCT DOSE OMISSION ISSUE (missed second dose (88 days since first one)). At the time of the report, ASTHENIA (weakness), BALANCE DISORDER (feeling out of balance) and PRODUCT DOSE OMISSION ISSUE (missed second dose (88 days since first one)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia, Vaccination site pruritus
Clinical narrative: Really bad chills; fatigue; 3 inch rash on right arm, which itched for a little while; 3 inch rash on right arm; High fever of 101.3 degrees Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (3 inch rash on right arm, which itched for a little while), VACCINATION SITE RASH (3 inch rash on right arm), PYREXIA (High fever of 101.3 degrees Fahrenheit), CHILLS (Really bad chills) and FATIGUE (fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 007MZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (3 inch rash on right arm, which itched for a little while), VACCINATION SITE RASH (3 inch rash on right arm) and PYREXIA (High fever of 101.3 degrees Fahrenheit). On an unknown date, the patient experienced CHILLS (Really bad chills) and FATIGUE (fatigue). On 11-Mar-2021, PYREXIA (High fever of 101.3 degrees Fahrenheit) had resolved. On 25-Apr-2021, CHILLS (Really bad chills) had resolved. At the time of the report, VACCINATION SITE PRURITUS (3 inch rash on right arm, which itched for a little while) and VACCINATION SITE RASH (3 inch rash on right arm) had resolved and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 101.3 (High) High fever of 101.3 degrees fahrenheit.         No concomitant medication was reported  It was reported that patient had persistent really bad chills and fatigue 'to beat the band', which started after the first dose of Moderna COVID-19 vaccine, that continued after second dose   No treatment medication was reported   This case was linked to MOD-2021-020152 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: No new information
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Really bad chills; fatigue; 3 inch rash on right arm, which itched for a little while; 3 inch rash on right arm; High fever of 101.3 degrees Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (3 inch rash on right arm, which itched for a little while), VACCINATION SITE RASH (3 inch rash on right arm), PYREXIA (High fever of 101.3 degrees Fahrenheit), CHILLS (Really bad chills) and FATIGUE (fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 007MZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (3 inch rash on right arm, which itched for a little while), VACCINATION SITE RASH (3 inch rash on right arm) and PYREXIA (High fever of 101.3 degrees Fahrenheit). On an unknown date, the patient experienced CHILLS (Really bad chills) and FATIGUE (fatigue). On 11-Mar-2021, PYREXIA (High fever of 101.3 degrees Fahrenheit) had resolved. On 25-Apr-2021, CHILLS (Really bad chills) had resolved. At the time of the report, VACCINATION SITE PRURITUS (3 inch rash on right arm, which itched for a little while) and VACCINATION SITE RASH (3 inch rash on right arm) had resolved and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 101.3 (High) High fever of 101.3 degrees fahrenheit.         No concomitant medication was reported  It was reported that patient had persistent really bad chills and fatigue 'to beat the band', which started after the first dose of Moderna COVID-19 vaccine, that continued after second dose   No treatment medication was reported   This case was linked to MOD-2021-020152 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: No new information
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Chills; FEVER; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (FEVER) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.No concomitant medication was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced CHILLS (Chills) and PYREXIA (FEVER). At the time of the report, CHILLS (Chills) and PYREXIA (FEVER) outcome was unknown.     Treatment medication was not provided  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache lasted 2 to 3 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-094881 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-094881:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site pain
Clinical narrative: Chills; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and INJECTION SITE PAIN (Pain at injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced CHILLS (Chills) and INJECTION SITE PAIN (Pain at injection site). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, CHILLS (Chills) and INJECTION SITE PAIN (Pain at injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up received on 28-may-2021 contain no new information
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Pyrexia, Vaccination site pain
Clinical narrative: sweating; fever started at 11pm and through the night; Little Headache; arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Little Headache), VACCINATION SITE PAIN (arm hurt), HYPERHIDROSIS (sweating) and PYREXIA (fever started at 11pm and through the night) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HEADACHE (Little Headache) and VACCINATION SITE PAIN (arm hurt). On 27-Apr-2021, the patient experienced PYREXIA (fever started at 11pm and through the night). On 28-Apr-2021, the patient experienced HYPERHIDROSIS (sweating). At the time of the report, HEADACHE (Little Headache), VACCINATION SITE PAIN (arm hurt), HYPERHIDROSIS (sweating) and PYREXIA (fever started at 11pm and through the night) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.      This case linked to MOD-2021-095147 (Patient Link).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Dizziness, Vertigo
Clinical narrative: Dizzy; Vertigo; Feeling Disoriented; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), VERTIGO (Vertigo) and DISORIENTATION (Feeling Disoriented) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS.   On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced DIZZINESS (Dizzy), VERTIGO (Vertigo) and DISORIENTATION (Feeling Disoriented). At the time of the report, DIZZINESS (Dizzy), VERTIGO (Vertigo) and DISORIENTATION (Feeling Disoriented) outcome was unknown.            No treatment indication was provided by the reporter.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone, Chest pain, Dyspnoea, Thyroid hormones increased
Clinical narrative: Thyroid hormone levels increased; Breathing problems; Chest Pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THYROID HORMONES INCREASED (Thyroid hormone levels increased), DYSPNOEA (Breathing problems) and CHEST PAIN (Chest Pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hyperthyroidism.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced THYROID HORMONES INCREASED (Thyroid hormone levels increased), DYSPNOEA (Breathing problems) and CHEST PAIN (Chest Pain). At the time of the report, THYROID HORMONES INCREASED (Thyroid hormone levels increased), DYSPNOEA (Breathing problems) and CHEST PAIN (Chest Pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Blood thyroid stimulating hormone: increased (High) Thyroid hormone levels increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The reporter was calling on behalf of their wife who received their 1st dose of Moderna vaccine and post receiving the vaccine the patient had breathing problems, chest pain and their thyroid hormone levels increased that the patient ended up going to hospital.   Reportedly, the patient had a medical history of thyroid  No Concomitant product use was reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Developed severe joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Developed severe joint pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced ARTHRALGIA (Developed severe joint pain). At the time of the report, ARTHRALGIA (Developed severe joint pain) outcome was unknown.            Patient walks with a cane due to arthritis. No relevant concomitant medications reported. No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided   Reporter did not allow further contact
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Abdomen scan, Abdominal distension, Blood test, Feeding disorder, Flatulence
Clinical narrative: she lost a couple of pounds; swollen abdomen; Nausea; vomiting,Vomits two or three times a day; gases; she isn't able to eat; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FLATULENCE (gases), FEEDING DISORDER (she isn't able to eat), WEIGHT DECREASED (she lost a couple of pounds), ABDOMINAL DISTENSION (swollen abdomen) and NAUSEA (Nausea) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced FLATULENCE (gases), FEEDING DISORDER (she isn't able to eat), WEIGHT DECREASED (she lost a couple of pounds), ABDOMINAL DISTENSION (swollen abdomen), NAUSEA (Nausea) and VOMITING (vomiting,Vomits two or three times a day). The patient was treated with ONDANSETRON (oral) for Nausea, at an unspecified dose and frequency. At the time of the report, FLATULENCE (gases), FEEDING DISORDER (she isn't able to eat), WEIGHT DECREASED (she lost a couple of pounds), ABDOMINAL DISTENSION (swollen abdomen), NAUSEA (Nausea) and VOMITING (vomiting,Vomits two or three times a day) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Abdomen scan: negative (Negative) Results are normal. In April 2021, Blood test: negative (Negative) Results are normal. In April 2021, Urine analysis: negative (Negative) Results are normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Urine analysis, Vomiting, Weight decreased
Clinical narrative: she lost a couple of pounds; swollen abdomen; Nausea; vomiting,Vomits two or three times a day; gases; she isn't able to eat; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FLATULENCE (gases), FEEDING DISORDER (she isn't able to eat), WEIGHT DECREASED (she lost a couple of pounds), ABDOMINAL DISTENSION (swollen abdomen) and NAUSEA (Nausea) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced FLATULENCE (gases), FEEDING DISORDER (she isn't able to eat), WEIGHT DECREASED (she lost a couple of pounds), ABDOMINAL DISTENSION (swollen abdomen), NAUSEA (Nausea) and VOMITING (vomiting,Vomits two or three times a day). The patient was treated with ONDANSETRON (oral) for Nausea, at an unspecified dose and frequency. At the time of the report, FLATULENCE (gases), FEEDING DISORDER (she isn't able to eat), WEIGHT DECREASED (she lost a couple of pounds), ABDOMINAL DISTENSION (swollen abdomen), NAUSEA (Nausea) and VOMITING (vomiting,Vomits two or three times a day) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Abdomen scan: negative (Negative) Results are normal. In April 2021, Blood test: negative (Negative) Results are normal. In April 2021, Urine analysis: negative (Negative) Results are normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second dose not administered within 36days; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose not administered within 36days) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose not administered within 36days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose not administered within 36days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications was reported.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Discomfort
Clinical narrative: felt uncomfortable after receiving Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (felt uncomfortable after receiving Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (felt uncomfortable after receiving Moderna vaccine). At the time of the report, DISCOMFORT (felt uncomfortable after receiving Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient not sure after which dose event occurred. No relevant concomitant medications reported. No treatment information was provided.   This case was linked to MOD-2021-095271 (Patient Link).   Reporter did not allow further contact
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient who has received Moderna and J&J in one week; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient who has received Moderna and J&J in one week) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Tramadol).    On 16-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient who has received Moderna and J&J in one week). On 16-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient who has received Moderna and J&J in one week) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter. Treatment information was not provided.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second shot potentially greater than day 36; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Apr-2021 and was forwarded to Moderna on 28-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second shot potentially greater than day 36) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No medical history was reported by reporter.     On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second shot potentially greater than day 36). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Hyperhidrosis, Pyrexia
Clinical narrative: sweating; fever is still 100.8F; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating) and PYREXIA (fever is still 100.8F) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced HYPERHIDROSIS (sweating). 28-Apr-2021, the patient experienced PYREXIA (fever is still 100.8F). The patient was treated with PARACETAMOL (TYLENOL) on 27-Apr-2021 for Pyrexia, at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (sweating) and PYREXIA (fever is still 100.8F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2021, Body temperature: 100.8 (Inconclusive) 100.8F.         Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator   Patient fell asleep after 2 hours, then patient woke up and felt bad again with the fever, sweating, then repeat.Patient took Tylenol at 11:00pm on 27Apr2021, at 5:00am and 9:30am on 28Apr2021, patient felt ok for 1 hour, the fever is still 100.8F, and patient took Tylenol, after 2 hours the Tylenol did not work.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pyrexia, Rash erythematous
Clinical narrative: red rash; low grade fever; joints hurting; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (red rash), PYREXIA (low grade fever) and ARTHRALGIA (joints hurting) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     no medical history was reported.  Concomitant products included GABAPENTIN, LISINOPRIL, ESCITALOPRAM OXALATE (LEXAPRO), BUSPIRONE, CLONAZEPAM (KLONOPIN) and BUPRENORPHINE for an unknown indication.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (red rash), PYREXIA (low grade fever) and ARTHRALGIA (joints hurting). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (red rash), PYREXIA (low grade fever) and ARTHRALGIA (joints hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took Benadryl few night and helps until morning
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Pain in extremity
Clinical narrative: little redness; Chills; initial soreness in arm & soreness in arm has returned; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (initial soreness in arm & soreness in arm has returned), ERYTHEMA (little redness) and CHILLS (Chills) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN IN EXTREMITY (initial soreness in arm & soreness in arm has returned) and CHILLS (Chills). On 28-Apr-2021, the patient experienced ERYTHEMA (little redness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (initial soreness in arm & soreness in arm has returned), ERYTHEMA (little redness) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  Patient is actively experiencing symptoms which started on 28Apr2021, of soreness in arm has returned and a little redness.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Diarrhoea, Dizziness, Nausea, Urinary tract infection
Clinical narrative: Diarrhea; Diagnosed with Urinary Tract Infection; Nausea; Dizziness; Cold sweat; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), COLD SWEAT (Cold sweat), URINARY TRACT INFECTION (Diagnosed with Urinary Tract Infection), DIARRHEA (Diarrhea) and NAUSEA (Nausea) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Allergic reaction to antibiotics (Clindamycin) and Penicillin allergy. Concomitant products included METOPROLOL, MULTIVITAMINS [VITAMINS NOS], LUTEIN [XANTOFYL] and POTASSIUM for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced DIZZINESS (Dizziness), COLD SWEAT (Cold sweat) and NAUSEA (Nausea). On 23-Apr-2021, the patient experienced URINARY TRACT INFECTION (Diagnosed with Urinary Tract Infection). On 25-Apr-2021, the patient experienced DIARRHEA (Diarrhea). The patient was treated with ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency and SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) on 23-Apr-2021 for Urinary tract infection, at a dose of 1 dosage form for 10 days. At the time of the report, DIZZINESS (Dizziness), COLD SWEAT (Cold sweat) and NAUSEA (Nausea) outcome was unknown and URINARY TRACT INFECTION (Diagnosed with Urinary Tract Infection) and DIARRHEA (Diarrhea) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Complex B with C is the other concomitant medication reported by reporter.  Patient stated that on 27-28Apr2021 that she Feeling better, urinary tract infection/diarrhea resolving.
Sex: M
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: Patient friend claims that he developed gout after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (Patient friend claims that he developed gout after receiving the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GOUT (Patient friend claims that he developed gout after receiving the vaccine). At the time of the report, GOUT (Patient friend claims that he developed gout after receiving the vaccine) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.      Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow-up information received on 28-MAY-2021, contains no new information.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Muscle pain; Shoulder pain; All body tired; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain), ARTHRALGIA (Shoulder pain), FATIGUE (All body tired), HEADACHE (Headache) and PYREXIA (Fever) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Muscle pain), ARTHRALGIA (Shoulder pain), FATIGUE (All body tired), HEADACHE (Headache) and PYREXIA (Fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MYALGIA (Muscle pain) and ARTHRALGIA (Shoulder pain) had not resolved and FATIGUE (All body tired), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Patient took every day 2-3 Advil and Tylenol to ease
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: extreme arm soreness after receiving the vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (extreme arm soreness after receiving the vaccine.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (extreme arm soreness after receiving the vaccine.). At the time of the report, PAIN IN EXTREMITY (extreme arm soreness after receiving the vaccine.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.       This case was linked to MOD-2021-095271 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: I feel a little dizzy sporadically; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I feel a little dizzy sporadically) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (I feel a little dizzy sporadically). At the time of the report, DIZZINESS (I feel a little dizzy sporadically) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Granuloma annulare, Rash
Clinical narrative: granuloma annulare; rash under her mastectomy scars, around the torso, and between the toes; This spontaneous case was reported by a consumer and describes the occurrence of GRANULOMA ANNULARE (granuloma annulare) and RASH (rash under her mastectomy scars, around the torso, and between the toes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GRANULOMA ANNULARE (granuloma annulare) and RASH (rash under her mastectomy scars, around the torso, and between the toes). At the time of the report, GRANULOMA ANNULARE (granuloma annulare) and RASH (rash under her mastectomy scars, around the torso, and between the toes) outcome was unknown.            No concomitant medications were provided.  No treatment details pertained to the events were provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Illness, Myalgia, SARS-CoV-2 antibody test
Clinical narrative: Can't taste or smell from COVID.; Can't taste or smell from COVID.; Only got sick for 24 hours; Aches and body aches all over; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Only got sick for 24 hours), AGEUSIA (Can't taste or smell from COVID.), ANOSMIA (Can't taste or smell from COVID.) and MYALGIA (Aches and body aches all over) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (He still can't taste or smell from COVID.) on 12-May-2020. Concurrent medical conditions included Drug allergy (Allergic to Penicillin).    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced MYALGIA (Aches and body aches all over). On 08-Apr-2021, the patient experienced ILLNESS (Only got sick for 24 hours). On an unknown date, the patient experienced AGEUSIA (Can't taste or smell from COVID.) and ANOSMIA (Can't taste or smell from COVID.). On 08-Apr-2021, ILLNESS (Only got sick for 24 hours) and MYALGIA (Aches and body aches all over) had resolved. At the time of the report, AGEUSIA (Can't taste or smell from COVID.) and ANOSMIA (Can't taste or smell from COVID.) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-May-2020, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-095946 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Follow-up information received on 26-JUN-2021.Updated Patient demographics,medical history, Suspect drug  batch number.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness in the arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in the arm at the injection site) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006CZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced VACCINATION SITE PAIN (Soreness in the arm at the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness in the arm at the injection site) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. Treatment medication was not provided. Patient stated that after vaccination experienced soreness in the arm at the injection site. She stated It is starting to go away, but arm is still sore.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vertigo
Clinical narrative: Experienced spinning in the head; Pain all over body,Unable to move due to pain; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Experienced spinning in the head) and PAIN (Pain all over body,Unable to move due to pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 036821A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Cancer and Asthma. Concomitant products included GABAPENTIN and VERAPAMIL for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Mar-2021, the patient experienced VERTIGO (Experienced spinning in the head) and PAIN (Pain all over body,Unable to move due to pain). At the time of the report, VERTIGO (Experienced spinning in the head) and PAIN (Pain all over body,Unable to move due to pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.    This case was linked to MOD-2021-095210 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up information was received on 28-MAY-2021 and it contains no  significant inforamtion
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vaccination complication
Clinical narrative: Dizzy spells; Felt really really horrible; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy spells) and VACCINATION COMPLICATION (Felt really really horrible) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 047A21A) for COVID-19 vaccination.     The patient's past medical history included Vertigo.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced DIZZINESS (Dizzy spells) and VACCINATION COMPLICATION (Felt really really horrible). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, DIZZINESS (Dizzy spells) and VACCINATION COMPLICATION (Felt really really horrible) outcome was unknown. Not Provided          No concomitant medications reported by investigator   Patient stated that she has a history of vertigo but this time it's really bad, she's never experienced anything similar. She's been taking Benadryl at night (not during the day because she has to work) and it seems to help. She added that the pollen count in her location is currently high, and maybe that makes things worse.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow up received and no new information was provided.